For: | Li YL, Lin ML, He SQ, Jin JF. Sphingolipid metabolism affects the anticancer effect of cisplatin. World J Transl Med 2016; 5(1): 37-45 [DOI: 10.5528/wjtm.v5.i1.37] |
---|---|
URL: | https://www.wjgnet.com/2220-6132/full/v5/i1/37.htm |
Number | Citing Articles |
1 |
Piyasiri Chueakwon, Peeranat Jatooratthawichot, Krajang Talabnin, James R. Ketudat Cairns, Chutima Talabnin. Inhibition of Ceramide Glycosylation Enhances Cisplatin Sensitivity in Cholangiocarcinoma by Limiting the Activation of the ERK Signaling Pathway. Life 2022; 12(3): 351 doi: 10.3390/life12030351
|
2 |
Estefanía Moreno-Gordaliza, Maria Dolores Marazuela, Óscar Pastor, Alberto Lázaro, María Milagros Gómez-Gómez. Lipidomics Reveals Cisplatin-Induced Renal Lipid Alterations during Acute Kidney Injury and Their Attenuation by Cilastatin. International Journal of Molecular Sciences 2021; 22(22): 12521 doi: 10.3390/ijms222212521
|